K · As filed with the SEC

Kellanova cash flow statement, by quarter

The statement as Kellanova presents it in its 10-Q and 10-K: its own lines, labels and order. Tables over time lines up standardized figures across every filing.

CONSOLIDATED STATEMENT OF CASH FLOWS (Unaudited) · USD millions

USD millions	Q3 2025^† 3 months ended Sep 27, 2025	Q2 2025^† 3 months ended Jun 28, 2025	Q1 2025 3 months ended Mar 29, 2025	Q4 2024^† 3 months ended Dec 28, 2024	Q3 2024^† 3 months ended Sep 28, 2024	Q2 2024^† 3 months ended Jun 29, 2024	Q1 2024 3 months ended Mar 30, 2024	Q4 2023^† 3 months ended Dec 30, 2023
Operating activities
Net income	314^†	303^†	308	368^†	370^†	347^†	271	30^†
Adjustments to reconcile net income to operating cash flows:
Depreciation and amortization	94^†	91^†	92	94^†	92^†	95^†	86	81^†
Impairment of property	0^†	0^†	0	0^†	0^†	0^†	60	0^†
Postretirement benefit plan expense (benefit)	(5)^†	(6)^†	(6)	—	(6)^†	(8)^†	(18)	—
Deferred income taxes	14^†	19^†	68	37^†	(43)^†	1^†	29	(21)^†
Stock compensation	(5)^†	14^†	22	—	25^†	20^†	21	—
Loss on Russia divestiture	—	—	—	0^†	—	—	—	0^†
Other	(26)^†	6^†	(23)	(83)^†	1^†	(18)^†	36	31^†
Postretirement benefit plan distributions	0^†	0^†	0	0^†	0^†	0^†	175	0^†
Postretirement benefit plan contributions	(12)^†	(133)^†	(12)	0^†	(23)^†	(10)^†	(22)	(29)^†
Changes in operating assets and liabilities, net of acquisitions and divestitures:
Trade receivables	(27)^†	(90)^†	16	87^†	(14)^†	(4)^†	(173)	187^†
Inventories	57^†	4^†	(46)	18^†	(21)^†	9^†	(4)	70^†
Accounts payable	(70)^†	26^†	(106)	(106)^†	81^†	77^†	(14)	(308)^†
All other current assets and liabilities	169^†	(65)^†	(197)	8^†	91^†	(133)^†	(83)	13^†
Net cash provided by (used in) operating activities	503^†	169^†	116	467^†	553^†	376^†	364	245^†
Investing activities
Additions to properties	(144)^†	(148)^†	(176)	(188)^†	(143)^†	(142)^†	(155)	(171)^†
Issuance of notes receivable	—	—	—	0^†	0^†	0^†	0	0^†
Repayments of notes receivable	—	—	—	—	—	—	—	0^†
Purchase of marketable securities	0^†	(2)^†	(72)	(49)^†	(124)^†	(2)^†	(175)	0^†
Sales of marketable securities	14^†	14^†	84	64^†	132^†	13^†	—	0^†
Purchases of available for sale securities	—	—	—	0^†	0^†	0^†	0	0^†
Sales of available for sale securities	—	—	—	0^†	0^†	0^†	0	49^†
Settlement of net investment hedges	(21)^†	(34)^†	0	0^†	0^†	0^†	(7)	39^†
Collateral paid on derivatives	—	—	—	—	—	0^†	0	—
Other	(5)^†	0^†	12	12^†	0^†	10^†	4	(7)^†
Net cash provided by (used in) investing activities	(156)^†	(170)^†	(152)	(161)^†	(135)^†	(121)^†	(333)	(90)^†
Financing activities
Net issuances (reductions) of notes payable	(253)^†	199^†	474	—	(73)^†	(30)^†	115	—
Issuances of long-term debt	0^†	—	—	0^†	0^†	619^†	0	(492)^†
Reductions of long-term debt	0^†	(1)^†	(631)	(1)^†	(2)^†	(650)^†	(2)	(553)^†
Net issuances of common stock	14^†	46^†	42	23^†	145^†	22^†	23	9^†
Common stock repurchases	—	—	—	0^†	0^†	—	—	(110)^†
Cash dividends	(203)^†	(198)^†	(197)	(196)^†	(197)^†	(192)^†	(191)	(190)^†
Other	(13)^†	(14)^†	(1)	(4)^†	0^†	(1)^†	(3)	(8)^†
Net cash provided by (used in) financing activities	(455)^†	32^†	(313)	(190)^†	(127)^†	(232)^†	(58)	(990)^†
Effect of exchange rate changes on cash and cash equivalents	(6)^†	(7)^†	(15)	9^†	6^†	7^†	(5)	10^†
Increase (decrease) in cash and cash equivalents	(114)^†	24^†	(364)	125^†	297^†	30^†	(32)	(825)^†
Cash and cash equivalents at beginning of period	354	330	694	569	272	242	274	1,099
Cash and cash equivalents at end of period	240	354	330	694	569	272	242	274
Supplemental cash flow disclosures of non-cash investing activities
Additions to properties included in accounts payable	(20)^†	(17)^†	116	48^†	(5)^†	11^†	88	31^†

† Derived: worked out from the filings, not stated in them. A fourth quarter is the 10-K year less the nine months in the third-quarter 10-Q; a quarter of cash flows is year to date less the prior year to date.

As filed on EDGAR · Not affiliated with the U.S. SEC · Not investment advice. Each column links to its filing.